Skip to main content
. 2008 Nov 4;87(1):64–71. doi: 10.2471/BLT.07.046375

Table 2. Countries that have declared measles elimination and how they meet the WPRO criteria.

WPRO criteria on measles elimination4 Target Australia Brazil Canada Cuba England & Wales Finland Mexico Republic of Korea USA
Very low incidence 1. Confirmed measles cases (confirmed by laboratory, epidemiologic linkage or clinically) < 1/1 million Noa Yes Noa Yes Noa b Yes Yes Yes

High quality surveillance 2. National reporting of non-measles suspected cases ≥ 2/ 100 000 No 3.3–4.9/ 100 000 ~17–22/ 100 000c ~4.4/ 100 000 ~10/ 100 000 Yes Yesd
3. Percentage of districts reporting ≥ 1/100 000 non-measles suspected cases ≥ 80% Noe
4. Percentage of suspected cases with adequate investigation within 48 hours of notification ≥ 80% NFIf Yes Yes
5. Percentage of suspected cases with adequate blood specimens ≥ 80% Yes Yes Yes
6. Percentage of specimens with laboratory results ≤ 7 days after arrival to laboratory ≥ 80% NFIg NFIh Yes
7. Transmission chains (outbreaks) with sufficient samples for virus isolation ≥ 80% No Yes

High population immunity 8. National MCV1 and MCV2 coverage ≥ 95% Yes Yes NFIi Noj No Yes Yes Yes NFIk
9. Percentage of outbreaks or transmission foci with < 10 cases ≥ 80% No Yes Yes Yes
10. Absence of endemic measles virus No virus Yes Yes Yes Yes Yesl Yes

MCV, measles-containing vaccine; NFI, no further information; USA, United States of America; WPRO, WHO Regional Office for the Western Pacific.
a Target achieved for some years only.
b Dash indicates criteria is not described in report that declared measles elimination for that country.
c Canada: includes confirmed measles cases.
d USA: > 90% of sources of data on discarded measles investigations in the USA report a rate > 1/100 000 population. Data sources vary in national completeness.
e Republic of Korea: national data only.
f Brazil: Policy of targeted investigation within 48 hours, NFI.
g Brazil: reporting of % of specimens with results within 4 days: In 2000, 67%, in 2001, 73% of specimens. NFI regarding results at 7 days.
h Mexico: reported > 80% of specimens arriving in a “timely fashion.” NFI.
i Canada: > 95% coverage for MCV1 achieved. NFI.
j Cuba: Vaccination strategy included one dose only.
k USA: reporting of at least one dose (MCV1+), 2 states only require 1 dose of MCV.
l Republic of Korea: previous endemic strain (H1) resulted in small outbreak in 2006. Likely imported from neighbouring country, China.